D Ginestet

732 total citations
46 papers, 562 citations indexed

About

D Ginestet is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, D Ginestet has authored 46 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 9 papers in Pharmacology and 5 papers in Clinical Psychology. Recurrent topics in D Ginestet's work include Treatment of Major Depression (7 papers), Schizophrenia research and treatment (6 papers) and Attention Deficit Hyperactivity Disorder (3 papers). D Ginestet is often cited by papers focused on Treatment of Major Depression (7 papers), Schizophrenia research and treatment (6 papers) and Attention Deficit Hyperactivity Disorder (3 papers). D Ginestet collaborates with scholars based in France and Canada. D Ginestet's co-authors include Emmanuelle Corruble, J Guelfi, P. Hardy, M.C. Masure, A Féline, Christian Trichard, J. L. Martinot, E. Zarifian, H. Löo and J F Bach and has published in prestigious journals such as American Journal of Psychiatry, Trends in Pharmacological Sciences and Psychological Medicine.

In The Last Decade

D Ginestet

42 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D Ginestet France	7	241	162	130	126	108	46	562
Daniel P. van Kammen United States	11	275 1.1×	138 0.9×	97 0.7×	95 0.8×	60 0.6×	12	587
Б. Спивак Israel	14	401 1.7×	149 0.9×	105 0.8×	110 0.9×	130 1.2×	31	775
Ivan N. Waldman United States	12	369 1.5×	115 0.7×	74 0.6×	152 1.2×	34 0.3×	19	610
Laurie A. Gillies Canada	6	121 0.5×	152 0.9×	30 0.2×	227 1.8×	115 1.1×	10	483
Christine Mohn Norway	14	341 1.4×	94 0.6×	72 0.6×	190 1.5×	105 1.0×	43	584
Ovidio A. De León United States	9	254 1.1×	109 0.7×	37 0.3×	101 0.8×	30 0.3×	19	435
Paul Soloff United States	6	182 0.8×	245 1.5×	25 0.2×	170 1.3×	63 0.6×	10	626
Thomas Bjella Norway	16	370 1.5×	243 1.5×	113 0.9×	132 1.0×	41 0.4×	34	721
T. Rolfe Australia	8	271 1.1×	95 0.6×	46 0.4×	48 0.4×	49 0.5×	12	474
Filip Rybakowski Poland	13	261 1.1×	201 1.2×	69 0.5×	103 0.8×	31 0.3×	66	594

Countries citing papers authored by D Ginestet

Since Specialization

Citations

This map shows the geographic impact of D Ginestet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Ginestet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Ginestet more than expected).

Fields of papers citing papers by D Ginestet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Ginestet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Ginestet. The network helps show where D Ginestet may publish in the future.

Co-authorship network of co-authors of D Ginestet

This figure shows the co-authorship network connecting the top 25 collaborators of D Ginestet. A scholar is included among the top collaborators of D Ginestet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Ginestet. D Ginestet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guelfi, J.D., et al.. (1999). Psychometric qualities of the French version of the Heinrichs quality of life rating scale. European Psychiatry. 14(7). 386–391. 8 indexed citations

Delay, J, et al.. (1998). [Clinical and polygraphic study of a new type of psycho-dysleptic agent: Ditran].. PubMed. 51. 539–47.

Ginestet, D. (1997). Efficacy of tianeptine in major depressive disorders with or without melancholia. European Neuropsychopharmacology. 7. S341–S345. 9 indexed citations

Corruble, Emmanuelle, D Ginestet, & J Guelfi. (1996). Comorbidity of personality disorders and unipolar major depression: A review. Journal of Affective Disorders. 37(2-3). 157–170. 143 indexed citations

Trichard, Christian, J. L. Martinot, M.C. Masure, et al.. (1995). Time course of prefrontal lobe dysfunction in severely depressed in-patients: a longitudinal neuropsychological study. Psychological Medicine. 25(1). 79–85. 186 indexed citations

Bourgeois, M, et al.. (1991). [Tianeptine in episodes of major depression with melancholia and signs of endogenicity].. PubMed. 20(37). 1837–43. 2 indexed citations

Cazas, Odile, et al.. (1990). [The hospitalization of a mother and her infant in an adult psychiatric department].. PubMed. 33(2). 635–74. 2 indexed citations

Ginestet, D, et al.. (1978). [Psychotropic effects of acebutolol in hebephrenics. Preliminary study].. PubMed. 32(3). 287–92. 1 indexed citations

Brion, S, et al.. (1976). [Chemotherapy of melancholia by sequential neuroleptic-viloxazine association].. PubMed. 2(3). 257–71.

10.

Ginestet, D, P Péron-Magnan, & P Deniker. (1976). Critical study of the use of long acting neuroleptics (depot neuroleptics) in France.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 9(4). 183–6. 1 indexed citations

11.

Ginestet, D. (1975). [Limits of efficacy and tolerance of antidepressive medications].. PubMed. 1(3). 203–10. 1 indexed citations

12.

Deniker, P, D Ginestet, P. Etévenon, & P Péron-Magnan. (1975). [Comparison of clinical effects of delta-9-tetrahydrocannabinol with the classic effects of hashish].. PubMed. 1(1). 33–41. 2 indexed citations

13.

Deniker, P, et al.. (1974). [Clinical pharmacology of delta-9-tetra-hydro-cannabinol in healthy volunteers with polygraphic control].. PubMed. 29(2). 185–200. 4 indexed citations

14.

Deniker, P, et al.. (1966). [Preliminary clinical evaluation of a new neuroleptic formula: thiothixene].. PubMed. 124(2). 196–202. 1 indexed citations

15.

Delay, J, et al.. (1966). [Research concerning new neuroleptic compounds. Efficacy of a dibenzothiazepine (HF 21.59)].. PubMed. 54(6). 525–31. 1 indexed citations

16.

Delay, J, et al.. (1966). [Neuro-psychic effects of gamma-hydroxybutyric acid by oral route and by venous route].. PubMed. 54(6). 546–54. 1 indexed citations

17.

Deniker, P, et al.. (1965). [Clinical and electroencephalographic study of neuroleptic dibenzothiazepine derivative: HF 21.59].. PubMed. 113(3). 264–6. 2 indexed citations

18.

Deniker, P, et al.. (1964). [EARLY CLINICAL EVALUATION OF THE NEUROLEPTIC PROPERTIES OF A NEW COMPOUND: DIBENZOTHIAZEPINE].. PubMed. 122. 402–7. 1 indexed citations

19.

Deniker, P, et al.. (1961). [Neuro-psychic effects of operations with prolonged circulatory arrest under deep hypothermia (neuro-psychiatric, psychometric and electroencephalographic balance)].. PubMed. 69. 2539–42. 5 indexed citations

20.

Ginestet, D, et al.. (1959). [3-(1-methyl-4-piperazinyl)propyl] phenothiazine (RP 7843)].. PubMed. 100. 778–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact